Related Experiment Video
Updated: Jun 19, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
A review of recent advances in anticancer activity and SAR of pyrazole derivatives
Heba A Hofny1,2, Mamdouh F A Mohamed1, Heba A Hassan2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt.
Abstract:
The present review serves to highlight the antitumor worth of pyrazole derivatives. Several active pyrazole-based anticancer compounds proposed by a huge number of scientists worldwide are reported. Regarding the development of novel pyrazole-based anticancer agents at a faster tone, there is a need to correlate the latest information with previously available information to understand the situation of this moiety in anticancer drug discovery studies. Herein, different anticancer pyrazoles are classified according to their mode of action at different anticancer targets. The results provided evidence that pyrazole derivatives have potential applications for the treatment of a variety of tumor types. From the study's findings, the structure-activity relationship (SAR) results demonstrated that all the compounds containing substituted pyrazole represent an important scaffold for anticancer activities. Publications in this area are increasing, and therefore, new therapeutic applications involving members of pyrazole derivatives could be discovered in the near future, as many prospects have not been sufficiently studied so far for other targets. In other words, this review provides an overview of the state of knowledge about the structural characteristics of the most recent anticancer pyrazole derivatives and their SAR with various targets. This will allow medicinal chemists to identify promising structures to guide the design and synthesis of more effective and safer anticancer candidates.
Related Concept Videos
Abnormal Proliferation
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

